A vaccine against coronavirus appears to have provided protection against the disease Covid-19 in six rhesus macaque monkeys.
It gives early hope for the vaccine, which is now undergoing human clinical trials.
There is no guarantee this result will translate to people, though.
The animals who had been given the vaccine, and were then exposed to SARS-CoV-2, had less of the virus in their lungs and airways.
That's compared with the control group of monkeys which was not given the vaccine.
The trial took place in the US, involving researchers from the US government's National Institutes of Health (NIH) and from the University of Oxford.
The vaccine appeared to protect the animals against developing pneumonia.
Rhesus macaques have similar immune systems to humans.
Promisingly, they also didn't develop "immune-enhanced disease" - which BBC medical correspondent Fergus Walsh describes as a "theoretical risk". That's when the vaccine triggers a worse response to a disease.
How close to developing a vaccine are we?
This response was seen in some early animal vaccine trials against SARS - another coronavirus - and proved a stumbling block in developing a vaccine for that disease.
The study hasn't yet been reviewed by other scientists and formally published, but Prof Stephen Evans at the London School of Hygiene and Tropical Medicine, described it as "high quality" and "very encouraging".
Meanwhile, trials in the UK on more than 1,000 human volunteers are currently taking place through the University of Oxford.
There are more than 100 experimental coronavirus vaccines currently being developed.
Dr Penny Ward, a visiting professor in pharmaceutical medicine at King's College London, said it was "helpful" to see that the vaccine didn't cause a worse disease response in these monkeys, and that they didn't develop pneumonia after being vaccinated.
The vaccine is based on a small part of the virus's distinctive "spike". The idea is that by getting the body to recognise a unique part of the virus, when it is exposed to the whole thing it will know how to react, and produce the right antibodies to fight it off.
That did seem to be happening to the vaccinated macaques, which produced antibodies capable of fighting the virus.
Latest Stories
-
We have a stable national grid; outages due to localised faults – ECG
3 mins -
Easter celebration: Ghana AIDS Commission to distribute free condoms in Kwahu
18 mins -
Zeepay secures additional $3m from Verdant Capital Hybrid Fund
25 mins -
Over 70% of power outages were due to planned maintenance works – ECG to PURC
28 mins -
Access Bank partners Horseman Shoes to boost local shoe manufacturing industry
40 mins -
Election 2024: Don’t vote for candidates making empty promises – CDD to Ghanaians
44 mins -
IGP shares Easter safety tips on Adom FM’s ‘Ofie Kwanso’
1 hour -
Ebo Whyte offers fully-funded trip as he unveils new play ‘Dubai or No Sex’
1 hour -
Ancient culture of Anlo Kingdom: Exploring “Torkor Atorlia,” the fifth landing stage’s old ways of punishment
2 hours -
Leaders from Saudi Arabia, Turkey, Botswana, Cameroon and Sierra Leone to lead discussions at Africa Finance Corporation’s (AFC) 4th Country & Stakeholder Symposium
2 hours -
Network International Delivers Strong 2023 Revenue growth at 15% y/y and free cashflow growth of 16% y/y
2 hours -
President Akufo-Addo extends Easter Greetings to Ghanaians, urges safe drive
2 hours -
Government pushes for use of more local materials in housing, other infrastructure projects
3 hours -
Dr Bawumia extends Easter greetings to Christians
3 hours -
CAF Confederation Cup: ‘Ghanaians should expect victory against Stade Malien’ – Dreams FC forward Ishmael Dede
4 hours